1. Market Research
  2. > Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review

Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Hovid Berhad (Hovid) is a pharmaceutical company that manufactures and commercializes pharmaceutical and herbal products. The company’s product portfolio consists of ethical drugs, pharmaceutical products, dietary supplements, tocotreienols and herbal tea. Hovid also specializes in special drug delivery systems including modified release formulations and bio-availability enhanced formulations. The company offers consumer products ranging from skin care, hair care and health beverages. Its research and development activities include drug delivery systems, nanotechnology research, clinical research, product development and specialized systems. The company has operations in Asia, Africa, the Americas, Europe, and the Pacific Island. Hovid is headquartered in Ipoh, Perak, Malaysia.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Hovid Berhad - Key Facts 6
Hovid Berhad - Key Employees 7
Hovid Berhad - Major Products and Services 8
Hovid Berhad - History 9
Hovid Berhad - Company Statement 12
Hovid Berhad - Locations And Subsidiaries 16
Head Office 16
Other Locations and Subsidiaries 16
Joint Venture 17
Section 2 - Company Analysis 18
Hovid Berhad - Business Description 18
Hovid Berhad - Corporate Strategy 19
Hovid Berhad - SWOT Analysis 20
SWOT Analysis - Overview 20
Hovid Berhad - Strengths 20
Strength - Research and Development Capabilities 20
Strength - Comprehensive Offerings 20
Strength - Distribution Network 20
Hovid Berhad - Weaknesses 21
Weakness - Decline in Asian Geographical segment 21
Hovid Berhad - Opportunities 22
Opportunity - Potential in the Malaysian Healthcare Industry 22
Opportunity - Market for Generics Exports 22
Opportunity - Business Initiatives 22
Hovid Berhad - Threats 23
Threat - Uncertain RandD Outcomes 23
Threat - Competitive Landscape 23
Threat - Stringent Government Regulations 23
Hovid Berhad - Key Competitors 24
Section 3 - Company Financial Ratios 25
Financial Ratios - Capital Market Ratios 25
Financial Ratios - Annual Ratios 26
Performance Chart 28
Financial Performance 28
Financial Ratios - Interim Ratios 29
Financial Ratios - Ratio Charts 30
Section 4 - Company's Lifesciences Financial Deals and Alliances 31
Hovid Berhad, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 31
Hovid Berhad, Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 32
Hovid Berhad, Recent Deals Summary 33
Section 5 - Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Hovid Berhad, Key Facts 6
Hovid Berhad, Key Employees 7
Hovid Berhad, Major Products and Services 8
Hovid Berhad, History 9
Hovid Berhad, Subsidiaries 16
Hovid Berhad, Joint Venture 17
Hovid Berhad, Key Competitors 24
Hovid Berhad, Ratios based on current share price 25
Hovid Berhad, Annual Ratios 26
Hovid Berhad, Interim Ratios 29
Hovid Berhad, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 31
Hovid Berhad, Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 32
Hovid Berhad, Recent Deals Summary 33
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

List of Figures
Hovid Berhad, Performance Chart (2011 - 2015) 28
Hovid Berhad, Ratio Charts 30
Hovid Berhad, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 31
Hovid Berhad, Pharmaceuticals and Healthcare, Deals by Type, 2009 to YTD 2015 32

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.